The Clinton Foundation’s Health Matters Initiative, in partnership with the Johns Hopkins Bloomberg School of Public Health, issued a report providing 49 recommendations under 10 topic areas on how to address the opioid crisis.
Pharmacologic-only approaches to the management of chronic pain seldom provide complete/adequate pain relief and experts advocate for an integrative approach to the management of chronic pain.
Researchers are working on a new technology that could potentially allow clinicians the ability to print multiple drugs onto a dissolvable strip, a microneedle patch, or another type of dosing device.
Long-term opioid prescription use increased threefold during a 16-year period between 1999 and 2014.
Researchers from the Feinstein Institute for Medical Research may have identified a potential cause for lupus, which may lead to new treatment options.
Ketamine was found to alleviate several pain modalities, and a number of clinical trials investigating its efficacy are ongoing.
Medical marijuana, as a botanical and a scheduled drug does not fit the FDA paradigm for drug approval, a major impediment to its use in research.
Dr Pamela Rist discusses her research in women with migraine and hypertension at the 2017 American Academy of Neurology Annual Meeting in Boston, MA. Scroll to below the video for a full text transcript of Dr Rist’s interview.
Policies have helped make naloxone more available, thus contributing to the reduction of opioid-related deaths in the U.S.